Insight Molecular Diagnostics Inc.
IMDX- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001642380
No open-market purchases or sales by Insight Molecular Diagnostics Inc. insiders were filed in the last 90 days; 40 institutions reported holding it in 13F filings for Q2 2026, worth $108.9M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Insight Molecular Diagnostics Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 86 | 2 | 76 | −8 |
| Shares | 54.4M | 24.1K | 68.7M | +14.4M (+26.5%) |
| Value | $81.1M | $36.0K | $61.8M | −$19.3M (−23.8%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Insight Molecular Diagnostics Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Millennium Management LLC | 996,169 | $896.0K | 0.00% |
| Ergoteles LLC | 232,133 | $209.0K | 0.01% |
| Susquehanna International Group, LLP | 145,804 | $131.0K | 0.00% |
| Qube Research & Technologies Ltd | 58,530 | $53.0K | 0.00% |
| LMR Partners LLP | 31,463 | $28.0K | 0.00% |
| Jump Financial, LLC | 29,140 | $26.0K | 0.00% |
| Cubist Systematic Strategies, LLC | 27,240 | $25.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 26,996 | $24.0K | 0.00% |
| Two Sigma Securities, LLC | 21,217 | $19.0K | 0.00% |
| Virtu Financial LLC | 20,741 | $19.0K | 0.00% |
| Engineers Gate Manager LP | 17,139 | $15.0K | 0.00% |
| HRT Financial LP | 13,941 | $12.0K | 0.00% |
| Balyasny Asset Management LLC | 10,796 | $10.0K | 0.00% |
| Credit Suisse AG | 32 | $0 | 0.00% |
| CoreCap Advisors, LLC | 5 | $0 | 0.00% |
Sold out (23)
Institutions that held Insight Molecular Diagnostics Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Nuveen Asset Management, LLC | 1,027,493 | $1.45M |
| Renaissance Technologies LLC | 157,450 | $235.0K |
| Dimensional Fund Advisors LP | 100,232 | $149.0K |
| Nisa Investment Advisors, LLC | 84,368 | $126.0K |
| Rhumbline Advisers | 60,355 | $90.0K |
| STRS Ohio | 50,300 | $74.0K |
| American International Group, Inc. | 29,874 | $45.0K |
| Voya Investment Management LLC | 27,904 | $42.0K |
| California State Teachers Retirement System | 25,949 | $39.0K |
| MML Investors Services, LLC | 25,500 | $38.0K |
| Allspring Global Investments Holdings, LLC | 24,078 | $35.0K |
| Invesco Ltd. | 21,653 | $32.0K |
| ProShare Advisors LLC | 20,825 | $31.0K |
| Manufacturers Life Insurance Company, The | 17,384 | $25.9K |
| Prudential Financial Inc | 14,405 | $21.0K |
| AQR Capital Management LLC | 13,512 | $20.0K |
| Amalgamated Bank | 9,138 | $14.0K |
| Legal & General Group Plc | 5,847 | $9.00K |
| Ameritas Investment Partners, Inc. | 5,296 | $8.00K |
| Koshinski Asset Management, Inc. | 2,200 | $3.28K |
| Simplex Trading, LLC | 1,860 | $2.00K |
| CWM, LLC | 100 | $0 |
| Carroll Investors, Inc | 300 | $0 |
Not filed for Q2 2022 yet (2)
Institutions that held Insight Molecular Diagnostics Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 14,969 | $22.0K |
| Amalgamated Financial Corp. | 9,138 | $14.0K |